Scott R. McDonnell

2.0k total citations · 2 hit papers
13 papers, 1.3k citations indexed

About

Scott R. McDonnell is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Scott R. McDonnell has authored 13 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 3 papers in Genetics. Recurrent topics in Scott R. McDonnell's work include Lymphoma Diagnosis and Treatment (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Immune Cell Function and Interaction (2 papers). Scott R. McDonnell is often cited by papers focused on Lymphoma Diagnosis and Treatment (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Immune Cell Function and Interaction (2 papers). Scott R. McDonnell collaborates with scholars based in United States, United Kingdom and Denmark. Scott R. McDonnell's co-authors include James G. Christensen, Joseph H. Lee, Gerrit Los, Gordon Alton, Barbara Mroczkowski, Maria E. Arango, Qiuhua Li, Helen Y. Zou, Shinji Yamazaki and Mitchell D. Nambu and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Cancer Research.

In The Last Decade

Scott R. McDonnell

12 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms

2007 593 citations Helen Y. Zou, Qiuhua Li et al. Cancer Research profile →
Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma

2007 513 citations James G. Christensen, Helen Y. Zou et al. Molecular Cancer Therapeutics profile →

Peers

Countries citing papers authored by Scott R. McDonnell

Since Specialization

Citations

This map shows the geographic impact of Scott R. McDonnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott R. McDonnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott R. McDonnell more than expected).

Fields of papers citing papers by Scott R. McDonnell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott R. McDonnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott R. McDonnell. The network helps show where Scott R. McDonnell may publish in the future.

Co-authorship network of co-authors of Scott R. McDonnell

This figure shows the co-authorship network connecting the top 25 collaborators of Scott R. McDonnell. A scholar is included among the top collaborators of Scott R. McDonnell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott R. McDonnell. Scott R. McDonnell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	A link between baseline neurofilament light chain and primary substrate accumulation in cerebrospinal fluid, and clinical outcomes in patients with MPS II from a phase 2/3 clinical trial and extension study of intrathecal idursulfase 2025 ·Molecular Genetics and Metabolism ·Christian Argueta, Oeystein Roed Brekk, (unknown), (unknown), (unknown), Scott R. McDonnell, Luying Pan, Tatiana Plavina, David Whiteman	1
2	Phase 1b study of the anti-CD38 antibody mezagitamab in patients with relapsed/refractory multiple myeloma 2024 ·PubMed ·(unknown), Krina K. Patel, Meera Mohan, Sundar Jagannath, Rubén Niesvizky, Rebecca Silbermann, (unknown), (unknown), Scott R. McDonnell, Deborah Berg, Keith Stockerl‐Goldstein	0
3	Mezagitamab in systemic lupus erythematosus: clinical and mechanistic findings of CD38 inhibition in an autoimmune disease 2024 ·Lupus Science & Medicine ·Scott R. McDonnell, (unknown), Noah M. Walton, Carsten Merkwirth, Feng Hong, (unknown), (unknown), Richard Furie	10
4	Molecular characterization of type I IFN-induced cytotoxicity in bladder cancer cells reveals biomarkers of resistance 2021 ·Molecular Therapy — Oncolytics ·Jennifer L. Green, Robin Osterhout, (unknown), Carsten Merkwirth, Scott R. McDonnell, Reza Beheshti Zavareh, Bryan C. Fuchs, Adeela Kamal, Jørn S. Jakobsen	12
5	Pyrimidine tract-binding protein 1 mediates pyruvate kinase M2-dependent phosphorylation of signal transducer and activator of transcription 3 and oncogenesis in anaplastic large cell lymphoma 2017 ·Laboratory Investigation ·Steven R. Hwang, Carlos Murga‐Zamalloa, Noah A. Brown, (unknown), Scott R. McDonnell, (unknown), Venkatesha Basrur, Ryan A. Wilcox, Kojo S.J. Elenitoba‐Johnson, Megan S. Lim	24
6	NPM-ALK phosphorylates WASp Y102 and contributes to oncogenesis of anaplastic large cell lymphoma 2016 ·Oncogene ·Carlos Murga‐Zamalloa, (unknown), Anagh A. Sahasrabuddhe, Delphine Rolland, Steven R. Hwang, Scott R. McDonnell, Andrew P. Sciallis, Ryan A. Wilcox, (unknown), Kojo S.J. Elenitoba‐Johnson, Megan S. Lim	14
7	Integrated phosphoproteomic and metabolomic profiling reveals NPM-ALK–mediated phosphorylation of PKM2 and metabolic reprogramming in anaplastic large cell lymphoma 2013 ·Blood ·Scott R. McDonnell, Steven R. Hwang, Delphine Rolland, Carlos Murga‐Zamalloa, Venkatesha Basrur, Kevin Conlon, Damian Fermin, Thomas Wolfe, Alexander Raskind, Chunhai Ruan, (unknown), Craig J. Thomas, Cory M. Hogaboam, Charles Burant, Kojo S.J. Elenitoba‐Johnson, Megan S. Lim	57
8	NPM-ALK signals through glycogen synthase kinase 3β to promote oncogenesis 2011 ·Oncogene ·Scott R. McDonnell, Steven R. Hwang, Venkatesha Basrur, Kevin Conlon, Damian Fermin, (unknown), Carlos Murga‐Zamalloa, (unknown), Youli Zu, Kojo S.J. Elenitoba‐Johnson, Megan S. Lim	29
9	The CARMA3-Bcl10-MALT1 Signalosome Promotes Angiotensin II-dependent Vascular Inflammation and Atherogenesis 2010 ·Journal of Biological Chemistry ·Linda M. McAllister‐Lucas, Xiaohong Jin, Shufang Gu, (unknown), Scott R. McDonnell, Jürgen Ruland, Phillip C. Delekta, (unknown), Peter C. Lucas	64
10	Pharmacological characterization of a small molecule inhibitor of c-Jun kinase 2008 ·American Journal of Physiology-Endocrinology and Metabolism ·(unknown), Shawn C. Black, (unknown), (unknown), Dawn Kelly-Sullivan, Sergei Timofeevski, Karen Lohmann Siegel, (unknown), Scott R. McDonnell, Ping Chen, Junming Yie, Kathleen M. Ogilvie, James D. Fraser, Celia P. Briscoe	22
11	An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms breakdown → 2007 ·Cancer Research ·Helen Y. Zou, Qiuhua Li, Joseph H. Lee, Maria E. Arango, Scott R. McDonnell, Shinji Yamazaki, Tatiana Koudriakova, Gordon Alton, Jingrong Jean Cui, (unknown), Mitchell D. Nambu, Gerrit Los, Steven L. Bender, Barbara Mroczkowski, James G. Christensen	593
12	Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma breakdown → 2007 ·Molecular Cancer Therapeutics ·James G. Christensen, Helen Y. Zou, Maria E. Arango, Qiuhua Li, Joseph H. Lee, Scott R. McDonnell, Shinji Yamazaki, Gordon Alton, Barbara Mroczkowski, Gerrit Los	513
13	LPS-induced biomarkers in mice: A potential model for identifying insulin sensitizers 2007 ·Biochemical and Biophysical Research Communications ·Celia P. Briscoe, (unknown), (unknown), (unknown), Scott R. McDonnell, Balkrishen Bhat	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact